 |
|
Researcher Profile - Celso Arango |
|
|
|
| First Name: | Celso | | Last Name: | Arango | | Title: | Dr | | Advanced Degrees: | MD PhD | | Affiliation: | Hospital General Universitario Gregorio Marañón | | Department: | Psychiatry | | Street Address 1: | Ibiza 43 | | City: | Madrid | | State/Province: | Madrid | | Zip/Postal Code: | 28009 | Country/Territory: | Spain | | Phone: | +34914265006 | | Fax: | +34914265004 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports the following financial or other potential conflicts of interest: [Last Modified: 16 August 2012]
Dr. Arango. has been a consultant to or has received honoraria or grants from Abbot, Astra Zeneca, Bristol-Myers Squibb, Caja Navarra, CIBERSAM, Fundación Alicia Koplowitz, Instituto de Salud Carlos III, Janssen Cilag, Lundbeck, Merck, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Ministerio de Economía y Competitividad, Mutua Madrileña, Otsuka, Pfizer, Roche, Servier and Schering Plough. |
Neurodevelopmental disorders (e.g., 22q11 deletion syndromes), Schizophrenia, Autism spectrum disorders (pervasive developmental disorders), Bipolar disorder
|
Brain imaging, Neuroanatomy/Systems Neuroscience, Neurodevelopment, Clinical trials, Glutamatergic transmission, Animal models, Pharmacology, Phenomenology/diagnosis
|
Research institute, Medical hospital
|
Academic Appointments
1999-2000 Attending Psychiatrist
Hospital General Universitario Gregorio Marañón
Madrid, Spain
1999-2005 Volunteer Adjunct Assistant Professor
University of Maryland School of Medicine
1999-2008 Associate Professor of Psychiatry
Complutense University of Madrid, Madrid, Spain
2000-2012 Head of Adolescent Psychiatric Unit
Hospital General Universitario Gregorio Marañón
Madrid, Spain
2005-present Volunteer Associate Professor of Psychiatry
University of Maryland School of Medicine
2009-present Associate Professor of Psychiatry
Complutense University of Madrid, Madrid, Spain
2012-present Head of Department
Department of Child and Adolescent Psychiatry
Hospital General Universitario Gregorio Marañón
Madrid, Spain
|
Arango, C.; Rapado Castro, M.; Reig, S.; Castro-Fornieles, J.; González-Pinto, A.; Otero Cuesta, S.; Baeza, I.; Moreno, C.; Graell, M.; Janssen, J.; Parellada, M.; Moreno, D.; Bargalló, N.; Desco, M. Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry, 69(1):16-26, 2012. (I.F.: 12.016).
Merchán-Naranjo, J.; Mayoral, M.; Rapado-Castro, M.; Llorente, C.; Boada, L.; Arango, C.; Parellada, M. Estimation of the Intelligence Quotient Using Wechsler Intelligence Scales in Children and Adolescents with Asperger Syndrome. Journal of Autism and Developmental Disorders, 42(1): 116-22, 2012. (I.F.: 3.341).
Parellada, M.; Moreno, C.; Mac-Dowell, K.; Leza, JC.; Giraldez, M.; Bailón, C.; Castro, C.; Miranda-Azpiazu, P.; Fraguas, D.; Arango, C. Plasma antioxidant capacity is reduced in Asperger syndrome. Journal of Psychiatry Research, 46(3):394-401, 2012. (I.F.: 4.664).
Janssen, J.; Aleman, Y.; Reig, S.; Schnack, H.; Parellada, M.; Graell, M.; Moreno, C.; Moreno, MD.; Mateos-Pérez, JM.; Udias, JM.; Arango, C.; Desco, M. Regional specificity of thalamic volume deficits in male adolescents with early-onset psychosis. British Journal of Psychiatry, 200: 30-6, 2012. (I.F.: 6.619).
Mayoral, M.; Bombín, I.; Castro-Fornieles, J.; González-Pinto, A.; Otero, S.; Parellada, M.; Moreno, D.; Baeza, I.; Graell, M.; Rapado, M.; Arango, C. Longitudinal study of neurological soft signs in first-episode early-onset psychosis. Journal of Child Psychology and Psychiatry, 53(3):323-31, 2012. (I.F.: 4.281).
Bobes, J.; Arango, C.; Aranda, P.; Carmena, R.; García-García, M.; Rejas, J.; on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study. European Psychiatry, 27(4): 267-274, 2012. (I.F.: 2.766).
Fischer, BA.; Keller, WR.; Arango, C.; Pearlson, GD.; McMahon, RP.; Meyer, WA.; Francis, A.; Kirkpatrick, B.; Carpenter, WT.; Buchanan, RW. Cortical structural abnormalities in deficit versus nondeficit schizophrenia. Schizophrenia Research, 136(1-3):51-4, 2012. (I.F.: 4.748).
Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C. Depression in Bipolar versus Major Depression Disorder: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Bipolar Disorders, 14(3): 271-82, 2012. (I.F.: 5.289).
Fraguas, D.; Gonzalez-Pinto, A.; Micó, JA.; Reig, S.; Parellada, M.; Martínez-Cengotitabengoa, M.; Castro-Fornieles, J.; Rapado-Castro, M.; Baeza, I.; Janssen, J.; Desco, M.; Leza, JC.; Arango, C. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophrenia Research, 137(1-3):58-65, 2012. (I.F.: 4.748).
Nuevo, R.; Chatterji, S.; Verdes, E.; Naidoo, N.; Arango, C.; Ayuso-Mateos, JL The Continuum of Psychotic Symptoms in the General Population: A Cross-national Study. Schizophrenia Bulletin, 38(3):475-85, 2012. (I.F.: 8.800).
Pina-Camacho, L.; Villero, S.; Fraguas, D.; Boada, L.; Janssen, J.; Navas-Sánchez, FJ.; Mayoral, M.; Llorente, C.; Arango, C.; Parellada, M. Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies. Journal of Autism and Developmental Disorders, 42(7):1326-41, 2012. (I.F.: 3.341).
|
Large cohort studies starting in pregnancy |
Many neurodevelopment disorders end up with a common final pathway that produces delusions and hallucinations. Schizophrenia is an artificial construct. |
Large epidemiological studies with GxE data |
|
|
|
|
|
